{"url_path":"/sec/nvacw/8-k/2026-04-27/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-04-27","source_url":"https://www.sec.gov/Archives/edgar/data/1859807/0001213900-26-048039-index.html","accession_number":"0001213900-26-048039","cik":"0001859807","ticker":"PFSA","issuer_name":"Profusa, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1859807/0001213900-26-048039-index.html","primary_entity_key":"0001859807","primary_entity_name":"Profusa, Inc."},"word_count":152,"has_tables":true,"body_markdown":"**Item 9.01 Financial Statements and Exhibits.**\n\n \n\n(d) Exhibits\n\n \n\n**Exhibit No.**\n \n**Description**\n\n2.1*\n \n\n[Asset Purchase Agreement, dated as of April 21, 2026, by and between Profusa Inc. and Bio Insights LLC](ea028768601ex2-1.htm)\n\n104\n \nCover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document)\n\n \n\n*Certain information has been\nredacted from this exhibit pursuant to Item 601(b)(10)(iv) of Regulation S-K because it is both not material and is the type of information\nthat is treated as private or confidential by the Registrant. The Registrant hereby agrees to furnish an unredacted copy of the exhibit\nto the SEC upon request.\n\n \n\n3\n\n \n\n**SIGNATURES**\n\n \n\nPursuant to the requirements\nof the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned\nhereunto duly authorized.\n\n \n\n \n**Profusa Inc.**\n\nDated: April 27, 2026\n \n\n \nBy:\n*/s/ Ben Hwang*\n\n \n \nBen Hwang\n\n \n \nChief Executive Officer\n\n \n\n \n\n4"}